Fredun Pharmaceuticals Share History & Returns 2016 to 2024
Fredun Pharmaceuticals Limited | |||
 | Price: ₹736.95 | ||
| 52 Week Low: ₹650.00 52 Week High: ₹1,054.00 | |||
| Market Capital: 268.1 Crore (Smallcap) | |||
| -> | |||
Show Table of Contents
Table of Contents
- 1: Fredun Pharmaceuticals Stock Highlights
- 1.1: 52-Week High Low
- 1.2: All Time High
- 2: Fredun Pharmaceuticals Recent Performance
- 3: Fredun Pharmaceuticals Stock Price Chart From 2016 to 2024
- 4: Fredun Pharmaceuticals Stock Price History Table From 2016 to 2024
- 5: Analyzing the Impact of Investing in Fredun Pharmaceuticals
- 5.1: Fredun Pharmaceuticals Stock Returns In Last 5 Years
- 6: Fredun Pharmaceuticals Returns vs Bank FD Returns
Fredun Pharmaceuticals Stock Highlights
As of 23 Dec 2024, Fredun Pharmaceuticals Stock price is ₹736.95 which is ₹317.05 below 52-week high of ₹1,054.00 and ₹86.95 above 52-week low of ₹650.00
52-Week High Low
- Fredun Pharmaceuticals 52-Week High is ₹1,054.00 occurred on 16 Feb 2024
- Fredun Pharmaceuticals 52-Week Low is ₹650.00 occurred on 13 Mar 2024
All Time High
- The all-time high or the highest price that Fredun Pharmaceuticals stocks have ever touched was ₹1,428.00 and this occurred on 01 Dec 2022.
- The highest closing price at which Fredun Pharmaceuticals stocks have ever closed was ₹1,324.45 recorded on 01 Nov 2022.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Fredun Pharmaceuticals Recent Performance
Over the past 15 trading days, the value of Fredun Pharmaceuticals's stock has decreased by ₹51.25 (-6.50%). On 03 Dec 2024, its one share was worth ₹788.2 and by 23 Dec 2024, the value dropped to ₹736.95. During this period it created a highest high of ₹810.00 and lowest low of ₹701.00.
Click on legend items to show/hide respective price lines
Fredun Pharmaceuticals Stock Price Chart From 2016 to 2024
Click on legend items to show/hide respective price lines
Fredun Pharmaceuticals Stock Price History Table From 2016 to 2024
| Year | Fredun Pharmaceuticals | YOY Chg% | ↑High - ↓Low |
|---|---|---|---|
| 2024 | ₹736.95 | -15.2% | ↑ ₹810.00 ↓ ₹701.00 |
| 2023 | ₹868.75 | -22.5% | ↑ ₹1,249.00 ↓ ₹740.00 |
| 2022 | ₹1,120.20 | 32.4% | ↑ ₹1,428.00 ↓ ₹675.00 |
| 2021 | ₹845.75 | 95.2% | ↑ ₹957.00 ↓ ₹346.00 |
| 2020 | ₹433.25 | 92.2% | ↑ ₹449.00 ↓ ₹103.00 |
| 2019 | ₹225.30 | -33.2% | ↑ ₹500.00 ↓ ₹183.00 |
| 2018 | ₹337.10 | 223.2% | ↑ ₹495.00 ↓ ₹104.00 |
| 2017 | ₹104.30 | 125.5% | ↑ ₹104.00 ↓ ₹48.55 |
| 2016 | ₹46.25 | - | ↑ ₹46.25 ↓ ₹12.50 |
Analyzing the Impact of Investing in Fredun Pharmaceuticals
Fredun Pharmaceuticals Stock price in the year 2016 was ₹46.25. If you had invested ₹10,000 in Fredun Pharmaceuticals Stock in 2016, in 8 years, your investment would have grown to ₹1.59 Lakh by the end of 2024. This represents a positive return of 1,493% from 2016 to 2024, with a compound annual growth rate (CAGR) of 41.3%.
Fredun Pharmaceuticals Stock Returns In Last 5 Years
- Its highest stock price in the last 5 years was: ₹1,428.00 and lowest was: ₹103.00
- Fredun Pharmaceuticals Stock price in 2019 was ₹225.30
- By 2024, its stock price rose to ₹736.95
- It gave a positive return of over 227.1% with a CAGR of 26.7% over the last 5 years
- If you had invested ₹10,000 in Fredun Pharmaceuticals in 2019 then in 5 years, your investment would have grown to ₹32,709.72 by 2024, which is 3.27 times of your initial investment.
Fredun Pharmaceuticals Returns vs Bank FD Returns
| Investment Type | Initial Amount | Final Value | Total Returns |
|---|---|---|---|
| Fredun Pharmaceuticals Shares | ₹10,000 | ₹1.59 Lakh | 1,493.4% |
| Bank FD (Simple Interest) | ₹10,000 | ₹14,800 | 48.0% |
| Bank FD (Compound Interest) | ₹10,000 | ₹15,938.48 | 59.4% |
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
